Tigecycline is an antibiotic used to treat various bacterial infections, including pneumonia, skin infections, and intra-abdominal infections. However, misuse of this drug can lead to severe consequences, including fatalities.

Tigecycline misuse can occur in several ways, such as using the drug to treat viral infections, using an incorrect dosage, or using it for an extended period than recommended. Misuse of tigecycline can lead to antibiotic resistance, which makes it difficult to treat bacterial infections in the future. Moreover, tigecycline has been associated with an increased risk of death compared to other antibiotics, particularly in patients with certain severe infections.

According to DrugPatentWatch.com, tigecycline is a patented drug, and its patent expired in 2018, which led to the introduction of generic versions of the drug. While the availability of generic versions has increased access to the drug, it also raises concerns about its misuse due to a lack of proper education and awareness about the drug's potential risks and side effects.

Healthcare professionals play a crucial role in preventing tigecycline misuse by ensuring that the drug is used appropriately and only when necessary. They should also monitor patients taking tigecycline for any adverse effects and adjust the treatment plan accordingly.

In summary, tigecycline misuse can lead to fatalities due to antibiotic resistance and an increased risk of death in certain patients. Healthcare professionals must ensure that tigecycline is used appropriately and monitor patients taking the drug for any adverse effects. The availability of generic versions of tigecycline has increased access to the drug, but it also raises concerns about its misuse.

Sources:

* DrugPatentWatch.com. (n.d.). Tigecycline. Retrieved from <https://www.drugpatentwatch.com/drugs/tigecycline>